DNA Topoisomerase II as a Target for Cancer Chemotherapy
- 1 January 2002
- journal article
- review article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 20 (4) , 570-589
- https://doi.org/10.1081/cnv-120002156
Abstract
(2002). DNA Topoisomerase II as a Target for Cancer Chemotherapy. Cancer Investigation: Vol. 20, No. 4, pp. 570-589.This publication has 112 references indexed in Scilit:
- The Product of the ABC Half-Transporter Gene ABCG2 (BCRP/MXR/ABCP) Is Expressed in the Plasma MembraneBiochemical and Biophysical Research Communications, 2000
- A truncated cytoplasmic topoisomerase IIα in a drug-resistant lung cancer cell line is encoded by aTOP2A allele with a partial deletion of exon 34International Journal of Cancer, 2000
- Sp3 Is a Bifunctional Transcription Regulator with Modular Independent Activation and Repression DomainsJournal of Biological Chemistry, 1997
- Antitopoisomerase drug action and resistancePublished by Elsevier ,1996
- Abasic Sites Stimulate Double-stranded DNA Cleavage Mediated by Topoisomerase IIJournal of Biological Chemistry, 1995
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase IIBiochemistry, 1991
- Cell cycle stage-dependent variations in drug-induced topoisomerase II mediated DNA cleavage and cytotoxicityBiochemistry, 1987
- Sequence dependence of Drosophila topoisomerase II in plasmid relaxation and DNA bindingJournal of Molecular Biology, 1987
- Novobiocin inhibition of DNA excision repair may occur through effects on mitochondrial structure and ATP metabolism, not on repair topoisomerasesCarcinogenesis: Integrative Cancer Research, 1985